• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝胆系统疾病中的皮肤表现。

Cutaneous manifestations in disorders of hepatobiliary system.

作者信息

Godara Shashi K, Thappa Devinder M, Pottakkatt Biju, Hamide Abdoul, Barath Jagadisan, Munisamy Malathi, Chiramel Minu J

机构信息

Department of Dermatology, Jawaharlal Institute of Medical Education and Research, Puducherry, India.

Department of Medical Gastroenterology, Jawaharlal Institute of Medical Education and Research, Puducherry, India.

出版信息

Indian Dermatol Online J. 2017 Jan-Feb;8(1):9-15. doi: 10.4103/2229-5178.198760.

DOI:10.4103/2229-5178.198760
PMID:28217465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5297287/
Abstract

BACKGROUND

Hepatobiliary diseases are associated with various mucocutaneous changes that are directly and indirectly associated with these diseases. There is a dearth of studies from India dealing with cutaneous manifestations in liver disorders.

AIM

This study was conducted to know the spectrum of cutaneous changes and their correlation with liver function tests in patients with disorders of hepatobiliary system.

METHODS

This was a descriptive study conducted among in patients and outpatients with primary hepatobiliary disorders at a tertiary care center in South India. Detailed history taking and examination was done. Visual analog score (VAS) and 5D itch score was employed to quantify pruritus. Correlation of liver function tests with pruritus and comparison of skin changes in the major disease groups was attempted.

RESULTS

A total of 303 patients were recruited. Hepatic mass/malignancy followed by nonalcoholic liver disease were the most common diagnoses. Icterus followed by pruritus were the most common cutaneous complaints. The mean VAS and 5D itch scores among the patients with pruritus were 4.7 ± 1.9 and 13.6 ± 4.9. The most common mucocutaneous findings observed were icterus (241 patients; 79.5%), ichthyosis/xerosis (172 patients; 56.7%), pallor (131 patients; 43.2%), excoriations (118 patients; 38.9%), hyperpigmented palmar creases (118 patients; 38.9%), clubbing (113 patients; 37.2%), and pedal edema (85 patients; 28%). There was statistically significant correlation between serum bilirubin levels and pruritus.

CONCLUSION

The common mucocutaneous manifestations associated with primary hepatobiliary disorders were icterus, ichthyosis/xerosis, pallor, excoriations, hyperpigmented palmar creases, clubbing, and pedal edema.

摘要

背景

肝胆疾病与多种皮肤黏膜改变相关,这些改变与这些疾病直接或间接相关。印度缺乏关于肝脏疾病皮肤表现的研究。

目的

本研究旨在了解肝胆系统疾病患者皮肤改变的范围及其与肝功能检查的相关性。

方法

这是一项在印度南部一家三级医疗中心对原发性肝胆疾病住院患者和门诊患者进行的描述性研究。进行了详细的病史采集和检查。采用视觉模拟评分(VAS)和5D瘙痒评分来量化瘙痒。尝试了肝功能检查与瘙痒的相关性以及主要疾病组皮肤改变的比较。

结果

共招募了303名患者。肝肿物/恶性肿瘤其次是非酒精性肝病是最常见的诊断。黄疸其次是瘙痒是最常见的皮肤主诉。瘙痒患者的平均VAS和5D瘙痒评分分别为4.7±1.9和13.6±4.9。观察到的最常见皮肤黏膜表现为黄疸(241例患者;79.5%)、鱼鳞病/皮肤干燥(172例患者;56.7%)、苍白(131例患者;43.2%)、抓痕(118例患者;38.9%)、掌纹色素沉着(118例患者;38.9%)、杵状指(113例患者;37.2%)和足部水肿(85例患者;28%)。血清胆红素水平与瘙痒之间存在统计学显著相关性。

结论

与原发性肝胆疾病相关的常见皮肤黏膜表现为黄疸、鱼鳞病/皮肤干燥、苍白、抓痕、掌纹色素沉着、杵状指和足部水肿。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/5297287/99f8189cb942/IDOJ-8-9-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/5297287/dddf485c6c0f/IDOJ-8-9-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/5297287/c10b42c96cc2/IDOJ-8-9-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/5297287/7433ea81c53e/IDOJ-8-9-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/5297287/73cc7ea67c13/IDOJ-8-9-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/5297287/93b86798fa23/IDOJ-8-9-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/5297287/99f8189cb942/IDOJ-8-9-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/5297287/dddf485c6c0f/IDOJ-8-9-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/5297287/c10b42c96cc2/IDOJ-8-9-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/5297287/7433ea81c53e/IDOJ-8-9-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/5297287/73cc7ea67c13/IDOJ-8-9-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/5297287/93b86798fa23/IDOJ-8-9-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ada9/5297287/99f8189cb942/IDOJ-8-9-g008.jpg

相似文献

1
Cutaneous manifestations in disorders of hepatobiliary system.肝胆系统疾病中的皮肤表现。
Indian Dermatol Online J. 2017 Jan-Feb;8(1):9-15. doi: 10.4103/2229-5178.198760.
2
Characteristics of Xerosis, Pruritus, and Pallor in Stage 5 Chronic Kidney Disease Patients Undergoing Hemodialysis at Dr. Hasan Sadikin General Hospital, Bandung.万隆哈桑·萨迪金综合医院接受血液透析的5期慢性肾病患者的皮肤干燥、瘙痒和面色苍白特征
Clin Cosmet Investig Dermatol. 2023 Sep 21;16:2613-2621. doi: 10.2147/CCID.S418776. eCollection 2023.
3
STUDY OF CUTANEOUS MANIFESTATIONS IN CHRONIC LIVER DISORDERS.慢性肝脏疾病的皮肤表现研究
Med J Armed Forces India. 1997 Oct;53(4):263-266. doi: 10.1016/S0377-1237(17)30750-5. Epub 2017 Jun 26.
4
Mucocutaneous Manifestations in Patients with Chronic Kidney Disease: A Cross-sectional Study.慢性肾脏病患者的皮肤黏膜表现:一项横断面研究。
Indian Dermatol Online J. 2018 Jan-Feb;9(1):20-26. doi: 10.4103/idoj.IDOJ_160_17.
5
Cutaneous manifestations of common liver diseases.常见肝脏疾病的皮肤表现
J Clin Exp Hepatol. 2011 Dec;1(3):177-84. doi: 10.1016/S0973-6883(11)60235-1. Epub 2012 Jan 2.
6
Mucocutaneous manifestations and nail changes in patients with end-stage renal disease on hemodialysis.血液透析的终末期肾病患者的皮肤黏膜表现及指甲改变
Saudi J Kidney Dis Transpl. 2013 Jan;24(1):36-40. doi: 10.4103/1319-2442.106236.
7
Dermatological manifestations in children with chronic kidney disease: a study from a North Indian tertiary care institute.儿童慢性肾脏病的皮肤表现:来自印度北部一家三级护理机构的研究。
Clin Exp Dermatol. 2021 Oct;46(7):1270-1276. doi: 10.1111/ced.14708. Epub 2021 Jun 24.
8
Severity of disease, rather than xerosis, correlates with pruritus in patients with atopic dermatitis.在特应性皮炎患者中,疾病的严重程度而非皮肤干燥与瘙痒相关。
Int J Dermatol. 2009 Apr;48(4):374-8. doi: 10.1111/j.1365-4632.2009.03906.x.
9
Mucocutaneous Adverse Reactions of Cancer Chemotherapy and Chemoradiation.癌症化疗和放化疗的皮肤黏膜不良反应
Indian J Dermatol. 2019 Mar-Apr;64(2):122-128. doi: 10.4103/ijd.IJD_129_17.
10
Cutaneous disorders in uremic patients on hemodialysis: an Egyptian case-controlled study.血液透析尿毒症患者的皮肤病变:一项埃及病例对照研究。
Int J Dermatol. 2010 Sep;49(9):1024-30. doi: 10.1111/j.1365-4632.2010.04466.x.

本文引用的文献

1
Extrahepatic metastases as initial manifestations of hepatocellular carcinoma: an Egyptian experience.肝外转移作为肝细胞癌的初始表现:埃及的经验
Diagn Pathol. 2015 Jun 30;10:82. doi: 10.1186/s13000-015-0313-1.
2
Cutaneous manifestations of common liver diseases.常见肝脏疾病的皮肤表现
J Clin Exp Hepatol. 2011 Dec;1(3):177-84. doi: 10.1016/S0973-6883(11)60235-1. Epub 2012 Jan 2.
3
Dermatologic manifestations of hepatitis C infection and the effect of interferon therapy: a literature review.丙型肝炎感染的皮肤表现及干扰素治疗的影响:文献复习。
Arch Iran Med. 2012 Jan;15(1):43-8.
4
Dermatologic disorders and the liver.皮肤疾病与肝脏。
Clin Liver Dis. 2011 Feb;15(1):165-82. doi: 10.1016/j.cld.2010.09.001.
5
A comparative study of liver function tests in patients of chronic liver disorders with and without cutaneous manifestations.对有和没有皮肤表现的慢性肝病患者的肝功能检查进行的一项对比研究。
Indian J Dermatol Venereol Leprol. 1997 Jan-Feb;63(1):15-9.
6
The effects of alcohol and drug abuse on the skin.酒精和药物滥用对皮肤的影响。
Clin Dermatol. 2010 Jul-Aug;28(4):391-9. doi: 10.1016/j.clindermatol.2010.03.024.
7
Hepatitis C virus infection and lichen planus: a systematic review with meta-analysis.丙型肝炎病毒感染与扁平苔藓:系统评价与荟萃分析。
Oral Dis. 2010 Oct;16(7):601-12. doi: 10.1111/j.1601-0825.2010.01670.x.
8
Nail changes in patients with liver disease.肝病患者的指甲变化。
J Eur Acad Dermatol Venereol. 2010 Jun;24(6):649-54. doi: 10.1111/j.1468-3083.2009.03476.x. Epub 2009 Nov 2.
9
Recognizing and treating cutaneous signs of liver disease.识别和治疗肝脏疾病的皮肤征象。
Cleve Clin J Med. 2009 Oct;76(10):599-606. doi: 10.3949/ccjm.76A.08113.
10
Skin manifestations of chronic hepatitis C virus infection in Cairo, Egypt.埃及开罗慢性丙型肝炎病毒感染的皮肤表现
East Mediterr Health J. 2009 May-Jun;15(3):692-700.